Reported results
- Net revenue increased 23% year-over-year to $257.1 million in Q1 fiscal 2027, compared to $209.5 million in Q1 fiscal 2026
- Gross profit increased 35% year-over-year to $77.5 million with gross margin expanding to 30% from 27%
- Beverage net revenue increased 82% year-over-year to $101.5 million; beverage gross margin expanded to 41% from 38%
- Cannabis net revenue was $56.1 million compared to $64.5 million; cannabis gross margin expanded to 39% from 36%
- Net loss (GAAP) was $40.0 million or $0.32 per share; adjusted net loss (non-GAAP) was $3.0 million or adjusted EPS of $0.02
- Adjusted EBITDA (non-GAAP) was $9.2 million compared to $10.2 million; cash, restricted cash and marketable securities totaled $221.4 million at quarter end
Guidance
- Fiscal year 2027 adjusted EBITDA (non-GAAP) guidance of $68 million to $75 million (reaffirmed), representing double-digit growth as compared to fiscal year 2026
Notes
The release notes that results are typically more weighted toward the second half of the fiscal year due to seasonality. All figures are reported in U.S. dollars unless otherwise indicated. Prior year share amounts have been retrospectively adjusted to reflect a reverse stock split effective December 2, 2025.
Price and volatility reaction
The stock moved -3.6% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -8.4 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 3.72 | 2026-10-07 |
| Close after release | 3.585 | 2026-10-08 |
| Realised move | -3.6% | close to close |
| 30d ATM IV change | -8.4 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-08 (8-K, Item 2.02). Read the original filing on sec.gov.
